We are live on ! Find out more
ACM

Atika Capital Management Portfolio holdings

AUM $796M
1-Year Est. Return 167.57%
This Fund
S&P 500
This Quarter Est. Return
+28.85%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$117M
AUM Growth
+$5.01M
Cap. Flow
-$4.67M
Cap. Flow %
-3.97%
Top 10 Hldgs %
39.15%
Holding
85
New
22
Increased
25
Reduced
13
Closed
24

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$2.7M
2
INCY icon
Incyte
INCY
+$2.45M
3
SCTY
SolarCity Corporation
SCTY
+$2.25M
4
INSY
Insys Therapeutics, Inc.
INSY
+$1.98M
5
LVS icon
Las Vegas Sands
LVS
+$1.97M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.91M
2
TCS
THE CONTAINER STORE GROUP, INC.
TCS
+$3M
3
MEG
Media General, Inc
MEG
+$2.88M
4
GENT
GENTIUM SPA ADS
GENT
+$2.63M
5
LNKD
LinkedIn Corporation
LNKD
+$2.49M

Sector Composition

Rank Sector Weight
1 Healthcare 36.91%
2 Industrials 12.76%
3 Communication Services 12.13%
4 Technology 6.3%
5 Materials 5.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPCM
51
PUT
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$589K 0.5%
+12,000
New +$639K
WWE
52
CALL
DELISTED
World Wrestling Entertainment
WWE
$523K 0.45%
+18,100
New +$431K
OMEX icon
53
Odyssey Marine Exploration
OMEX
$38.6M
$402K 0.34%
14,623
-6,877
-32% -$173K
RPTP
54
CALL
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
$350K 0.3%
+35,000
New +$505K
CORV
55
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$316K 0.27%
+40,000
New +$322K
ITMN
56
CALL
DELISTED
INTERMUNE INC
ITMN
$284K 0.24%
+8,500
New +$189K
ABUS icon
57
Arbutus Biopharma
ABUS
$861M
$279K 0.24%
+13,000
New +$234K
ARWR icon
58
Arrowhead Research
ARWR
$12.1B
$263K 0.22%
16,000
-39,100
-71% -$687K
RLOC
59
PUT
DELISTED
REACHLOCAL INC COM STK (DE)
RLOC
$211K 0.18%
21,400
– –
ISEE
60
CALL
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$182K 0.15%
+5,100
New +$172K
ACAD icon
61
CALL
Acadia Pharmaceuticals
ACAD
$4.39B
$78K 0.07%
+3,200
New +$81K
CPRI icon
62
Capri Holdings
CPRI
$1.88B
– –
-20,000
Closed -$1.62M
DGX icon
63
CALL
Quest Diagnostics
DGX
$25.6B
– –
-39,700
Closed -$2.13M
GILD icon
64
Gilead Sciences
GILD
$163B
– –
-52,100
Closed -$3.91M
JAZZ icon
65
Jazz Pharmaceuticals
JAZZ
$15.8B
– –
-16,650
Closed -$2.11M
MNRO icon
66
CALL
Monro
MNRO
$399M
– –
-18,700
Closed -$1.05M
MNRO icon
67
Monro
MNRO
$399M
– –
-11,650
Closed -$657K
PRGO icon
68
Perrigo
PRGO
$1.48B
– –
-7,200
Closed -$1.1M
QQQ icon
69
PUT
Invesco QQQ Trust
QQQ
$469B
– –
-43,000
Closed -$3.78M
TCS
70
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
– –
-4,297
Closed -$3M
WWE
71
DELISTED
World Wrestling Entertainment
WWE
– –
-63,200
Closed -$1.5M
CERN
72
DELISTED
Cerner Corp
CERN
– –
-20,000
Closed -$1.11M
ENT
73
DELISTED
Global Eagle Entertainment Inc.
ENT
– –
-644
Closed -$239K
AVP
74
CALL
DELISTED
Avon Products, Inc.
AVP
– –
-39,000
Closed -$672K
MDSO
75
DELISTED
Medidata Solutions, Inc.
MDSO
– –
-4,800
Closed -$290K
1 2
3
4

Similar funds

AGA
Arkos Global Advisors Houston, Texas $797M AUM 15.28% 1-Year Est. Return
RIM
Rovida Investment Management Grand Cayman, Cayman Islands $797M AUM 111.83% 1-Year Est. Return
ACM
Ashe Capital Management Englewood Cliffs, New Jersey $797M AUM 4.79% 1-Year Est. Return
CAM
CenterStar Asset Management Chicago, Illinois $797M AUM 28.71% 1-Year Est. Return
Legacy Financial Group (Iowa)
Legacy Financial Group (Iowa) Des Moines, Iowa $795M AUM 12.87% 1-Year Est. Return
LSA
L & S Advisors Los Angeles, California $795M AUM 52.77% 1-Year Est. Return
GWA
Geometric Wealth Advisors Washington, District of Columbia $799M AUM 22.19% 1-Year Est. Return
HP
Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

Atika Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, Atika Capital Management held 85 positions worth $117M, up 4.5% from $112M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Atika Capital Management withdrew a net $4.67M in Q1 2014, closing 24 positions and reducing 13 holdings. Its most notable exit was Gilead Sciences, an estimated $3.91M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 28% a quarter earlier, followed by Industrials and Communication Services.

Against the trend, Atika Capital Management opened a new position in Biogen worth $2.6M.

  • Atika Capital Management's largest Q1 2014 buy was Biogen: 8,500 shares worth $2.6M.
  • Atika Capital Management added most to Incyte in Q1 2014, an estimated $2.45M increase.
  • Atika Capital Management's biggest Q1 2014 reduction was Netflix, cutting an estimated $2.41M.
  • Atika Capital Management fully exited Gilead Sciences in Q1 2014, selling an estimated $3.91M.
  • Atika Capital Management's ten largest holdings make up 39% of its $117M portfolio in Q1 2014.
  • Atika Capital Management opened 22 new positions and closed 24 in Q1 2014.
  • Atika Capital Management's portfolio value rose 4.5% quarter-over-quarter to $117M.

Based on Atika Capital Management's 13F filing for Q1 2014, filed 15 May 2014.